Home

PB Ratio of Kilitch Drugs (india) Ltd

Image

Kilitch Drugs (India) Ltd

NSE: KILITCH

PB Ratio

2.5

Last updated on: Sep 12, 2025

Key Highlights

  • The latest PB Ratio of Kilitch Drugs (India) Ltd is 2.5.
  • The PB ratio of the Kilitch Drugs (India) Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Kilitch Drugs (India) Ltd changed from 1.1 on March 2020 to 2.9 on March 2025 . This represents a CAGR of 17.54% over 6 years.

Historical P/B Ratio of Kilitch Drugs (India) Ltd

No data available

Company Fundamentals for Kilitch Drugs (India) Ltd

Market Cap

629 Cr

EPS

16.0

P/E Ratio (TTM)

22.5

P/B Ratio (TTM)

2.5

Day’s High

372.0

Day’s Low

360.0

DTE

0.2

ROE

13.2

52 Week High

490.0

52 Week Low

265.5

ROCE

15.7

Market Price of Kilitch Drugs (India) Ltd

1M

1Y

3Y

5Y

Monitoring Kilitch Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Sep 2025360.35
11 Sep 2025365.5
10 Sep 2025367.35
09 Sep 2025359.7
08 Sep 2025363.1
05 Sep 2025372.35
04 Sep 2025361.5
03 Sep 2025354.5
02 Sep 2025355.6
01 Sep 2025355.25

SWOT Analysis Of Kilitch Drugs (India) Ltd

Strength

4

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Kilitch Drugs (India) Ltd

Asset Value vs Market Value of Kilitch Drugs (India) Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PB Ratio of Kilitch Drugs (India) Ltd Explained

629.92

Market cap

144

Book Value per Share

2.5X

PB Ratio

Historical Market Cap of Kilitch Drugs (India) Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Kilitch Drugs (India) Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Kilitch Drugs (India) Ltd News Hub

Kilitch Drugs (India) consolidated net profit declines 60.12% in the June 2024 quarter

Net profit of Kilitch Drugs (India) declined 60.12% to Rs 1.34 crore in the quarter ended June 2024

Read more

09 Aug 24

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 August 2024.

Read more

02 Aug 24

Kilitch Drugs (India) to convene AGM

Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company will be he

Read more

31 Aug 24

Kilitch Drugs (India) announces board meeting date

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 12 November 20

Read more

05 Nov 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Kilitch Drugs (India) Ltd

What is the PB ratio of Kilitch Drugs (India) Ltd?

The current PB ratio of Kilitch Drugs (India) Ltd is 2.5. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Kilitch Drugs (India) Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Kilitch Drugs (India) Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Kilitch Drugs (India) Ltd calculated?

The PB ratio of Kilitch Drugs (India) Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Kilitch Drugs (India) Ltd?

A high PB ratio suggests that Kilitch Drugs (India) Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Kilitch Drugs (India) Ltd?

A low PB ratio of Kilitch Drugs (India) Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Kilitch Drugs (India) Ltd PB Ratio change over time?

Yes, the PB ratio of Kilitch Drugs (India) Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions